APP and Alzheimer disease: Other studies indicate that deficiencies in estrogen-related steroids can exacerbate Aβ plaques in AD mouse models and that treatment with estradiol was able to reduce Aβ burden, possibly via stimulating the non-amyloidogenic pathway of APP processing [64, 67].